Physiotherapist-Supervised Online Exercise in Remote White-Collar Workers

March 30, 2026 updated by: Begüm Ünlü, Marmara University

Effect of a Physiotherapist-Supervised Online Exercise Program on Pain and Functional Performance in Remote White-Collar Workers

This study evaluates the effects of a physiotherapist-guided online exercise program on pain and functional performance in remote white-collar workers. It is designed as a prospective single-arm study to provide preliminary evidence on the clinical effectiveness of the intervention.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The expansion of remote working has increased interest in digital health approaches that can be delivered in the home setting. Among these, physiotherapist-supervised online exercise programs may offer an individualized and accessible intervention model, as they can be delivered through technological devices and tailored to each participant's physical needs.

Remote white-collar workers are often exposed to prolonged sitting, desk-based work, and limited movement during the day. These conditions can contribute to postural impairments and adverse musculoskeletal outcomes, including pain, reduced flexibility, decreased muscle performance, and limitations in daily functioning. Common postural deviations in desk-based workers include forward head posture, rounded shoulders, increased thoracic kyphosis, and reduced lumbar curvature. Such problems may negatively affect both physical comfort and functional performance.

Telerehabilitation-based exercise interventions can improve access to physiotherapy services while allowing participants to engage in structured exercise sessions without leaving their home or work environment. In this context, the present study is designed to evaluate the effects of a physiotherapist-supervised online exercise program on pain intensity and functional performance in remote white-collar workers and to provide preliminary evidence regarding the clinical effectiveness of this intervention model. Participants will undergo a six-week online exercise program supervised by a physiotherapist, consisting of two sessions per week, with each session lasting 40-50 minutes. Pain intensity will be measured using the Visual Analog Scale (VAS), and functional performance will be evaluated using the sit-up test, lateral bridge test, and bilateral squat test.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
33

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • White-collar individuals who have been working remotely for at least 3 months
  • Aged 18 years or older
  • Having low back pain and/or neck pain related to the remote working process, or reporting a perceived postural disorder
  • Having a sedentary lifestyle

Exclusion Criteria:

  • History of chronic disease
  • Presence of a neurological or psychiatric disorder
  • Visual or hearing impairment
  • Inability to cooperate with the study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Physiotherapist-Supervised Online Exercise Tranining
Online Exercise
Other: Online exercise program
The online exercise intervention in this study will consist of a structured program including a warm-up period, shoulder girdle stabilization exercises, stretching exercises for the upper and lower extremities, back extensor strengthening, lower-extremity balance and coordination training, and a cool-down period. All exercises will be delivered in an online setting under the supervision of a physiotherapist. Each exercise will be performed in two sets of 10 repetitions. The intervention will be implemented over a period of six weeks, with two sessions per week, and each session will last approximately 40 to 50 minutes. After completion of the baseline assessments, participants will begin the exercise program with a warm-up phase intended to increase cardiorespiratory activity and prepare the neuromuscular system for exercise. The warm-up will include marching in place, controlled breathing exercises, and shoulder abduction.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Change in Pain intensity
Time Frame: Baseline and the end of the 6 weeks exercise program
Pain intensity will be assessed using a 10-cm Visual Analog Scale (VAS). The VAS is a widely used self-reported measure of pain consisting of a horizontal line anchored by "no pain" at one end and "worst imaginable pain" at the other. Participants will be asked to mark the point on the line that best represents their pain intensity, and the score will be recorded in centimeters. Higher scores will indicate greater pain intensity.
Baseline and the end of the 6 weeks exercise program
Change in lower-extremity functional strength and endurance
Time Frame: Baseline and the end of the 6 weeks exercise program
Lower-extremity functional strength and endurance will be assessed using the bilateral squat test. The number of correctly performed repetitions completed in 30 seconds will be recorded.
Baseline and the end of the 6 weeks exercise program
Change in core muscle endurance
Time Frame: Baseline and the end of the 6 weeks exercise program
The lateral bridge test will assess core muscle endurance by recording the duration participants can maintain the side-bridge position. The duration for which the side-bridge position can be maintained will be recorded in seconds.
Baseline and the end of the 6 weeks exercise program
Change in abdominal and hip flexor muscle strength and endurance
Time Frame: Baseline and the end of the 6 weeks exercise program
The sit-up test will assess abdominal and hip flexor muscle strength and endurance by recording the number of correctly completed repetitions during the test period.
Baseline and the end of the 6 weeks exercise program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Marmara University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 17, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 1, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 1, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 17, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 24, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 30, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 3, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 30, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 25.01.2024/26

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Online exercise program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings